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Abstract
Formaldehyde is widely used in the healthcare industry. Formaldehyde is used as a disinfectant
and sterilant. In addition, formaldehyde/formalin is used as fixative/ preservative of anatomical
specimens in pathology departments. Individuals may experience adverse effects following short
term exposure above 0.1ppm. Following a laboratory study in the early 1980s, the U.S.
Environmental Protection Agency (EPA) classified formaldehyde as a human carcinogen in
1987.
Although the healthcare industry in the United States made major advancement in the safe use of
formaldehyde/formalin since the implementation of the Occupational Health and Safety
Administration (OSHA) Formaldehyde standard, other developing countries are still struggling
with the proper storage, handling and disposal of formaldehyde.
As part of a Joint Commission International (JCI) accreditation assessment team, a baseline
industrial hygiene exposure assessment took place in the Dominican Republic’s Hospital General
de la Plaza de la Salud. This assessment included conducting personal exposure and area
monitoring. In addition, an instantaneous monitoring device was use to detect any fluctuations/
Short Term Exposure Limit (STEL) conditions.
Even though the data listed is limited, it was concluded that a significant level of overexposure to
formaldehyde is expected during unplanned leaks from sterilizing equipment and the segregation
of specimens from formalin in the morgue area.
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1. Background
As the science and art devoted to the anticipation, recognition, evaluation, and control of
workplace conditions that may cause workers' injury or illness, industrial hygiene was first
recognized as early as the fourth century BC. Industrial hygienists use environmental monitoring
and analytical methods to detect the extent of worker exposure and employ engineering, work
practice controls, and other methods to control potential health hazards (Anna 2011).
As with all professions, the early years of occupational hygiene were full of challenges
and countless improvement opportunities. In 1713, the father of occupational medicine,
Bernardino Ramazzini, published the first complete dissertation on occupational diseases, De
Morbis Artificum Diatriba. Although at the time his recommendations were seen as
revolutionary in the advancement of health and safety for industrial workers, they lacked
specifics and support from organizations and legislative bodies, which play a key role in
providing the necessary resources and enforcement to a sound occupational hygiene program.
Unfortunately, no significant additions were made for the following 100 years (Anna 2011).

1.1.

The U.S. Experience

The United States provided many improvements in the further development of the
profession; however the U.S. experience was no different, as it took trial and error for the
practice to be finally recognized in the early 1900s. With the passing of the Metal and
Nonmetallic Mines Safety Act of 1966, the Federal Coal Mine Safety and Health Act of
1969, and the Occupational Safety and Health Act of 1970 (OSHAct), the U.S. Congress
made a major commitment to the advancement of health and safety in the workplace. Today,
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all employers are required to implement some or all of these elements into their workplace
safety program (Anna 2011).

1.2.

The Occupational Safety and Health Act of 1970 (OSHAct)

The OSH Act of 1970 sets occupational safety and health requirements within the
workplace. This includes the employer determining the extent of potential employee exposure
and making the necessary changes to mitigate those hazards. These hazards include potential air
contaminants, and harmful chemicals. In order to reduce the extent and severity of work related
injuries, one most establish a management program. (OSHA 1970). OSHA developed and
published the voluntary “Safety and Health Program Management Guidelines,” which identify
four critical elements to the development of a successful safety and health management program:
management commitment and employee involvement, worksite analysis, hazard prevention and
control, and safety and health training (OSHA 1990).

1.3.

National Institute for Occupational Safety and Health
(NIOSH)

In addition to the creation of OSHA, another significant part of the OSHAct was the
creation of NIOSH. NIOSH was founded to help ensure safe and healthful working conditions by
providing information, education, research, and training. One of NIOSH’s greatest contributions
was the publication of the NIOSH Pocket Guide. The Pocket Guide provides general industrial
hygiene information for several chemicals or substance groupings that are found in the
workplace. Data is illustrated in tabular form to provide a clear, expedient source of information.
about monitoring practices (NIOSH 1990).

11

Table 1-Major Historical Events in IH
1,000,000 BC

Australopithecus used stones as tools and weapons. Flint knappers
suffered cuts and eye injuries; bison hunters contracted anthrax.

370 BC

Hippocrates dealt with the health of citizens, not workers, but did
identify lead poisoning in miners and metallurgists.

Middle Ages

No documented contributions

1500

Paracelsus described respiratory diseases among miners with an
excellent description of mercury poisoning. Remembered as the father
of toxicology. “All substances are poisons . . . the right dose
differentiates a poison and a remedy.”

1713

Bernardino Ramazzini, “father of occupational medicine.” Published
De Morbis Artificum, (Disease of Workers) and examined
occupational diseases and “cautions.” He introduced the questions, “of
what trade are you?”

1830

Charles Thackrah authored the first book on occupational diseases to be
published in England. His views on disease and prevention helped
stimulate factory and health legislation. Medical inspection and
compensation were established in 1897.

1900s

Dr. Alice Hamilton investigated many dangerous occupations and had
tremendous influence on early regulation of occupational hazards in
the United States. In 1919 she became the first woman faculty member
at Harvard University and wrote Exploring the Dangerous Trades.

1930s

American Industrial Hygiene Association organized. American
Standards Association and ACGIH prepared first list (maximum
allowable concentrations) of standards for chemical exposures in
industry.

1960-Present

Metal and Nonmetallic Mine Safety Act, Coal Mine Health and Safety
Act, Occupational Safety and Health Act, efforts to significantly
amend OSHAct

1.4.

The Dominican Republic Experience

Known for its main industries; agriculture and mining, the economy has recently moved
into a period of domination from the service industry. Although founded in 1929, the country’s
Ministry of Labor has only made minor improvements since, primarily in passing legislation,
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but continues to face many challenges in enforcing and providing employers with an effective
roadmap, through program management and education, to achieving full compliance.
Similar to the U.S. Occupational Safety and Health Act (OSHAct) of 1970, the
Dominican Republic’s landmark Reglamento de Segurida y Salud en el Trabajo, Decreto 52206 (Health and Safety in the Workplace Act of 2006), set out to make major improvements
within the workplace. This Act regulates some hazards within the workplace and requires
employers to establish risk prevention initiatives, to include program management, in order to
prevent illnesses and accidents within the workplace.

1.5.

Health and Safety in the Workplace Act of 2006

On October 17, 2006, the Dominican Congress passed its version of the OSHAct;
Reglamento de Seguridad y Salud en el Trabajo (Decreto 522-06). The main objective of this
landmark mandate is to establish and maintain safe working conditions within the workplace,
which will ultimately result in the prevention of injuries and illnesses. Under the Ministry of
Labor, the Secretary of Labor’s Hygiene and
Safety

Department

is

tasked

with

the

responsibility to oversee the evaluation and
investigation of potential risk within the
workplace and with promoting preventive
programs within the workplace. This includes
working with employers to create and maintain
a successful health and safety program.
Under section 3.2.4 of this Act, a “tabla
indicative y No Exhaustiva De Valores Limite”

Figure 1: Health and Safety Act of 2006
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or TLV-TWA table is included. This table includes TWA limits for over 82 hazardous
substances. Noteworthy, this TLV table does not include any IDLH, TLV-C or TLV STEL
requirements. In addition, this table or the Act does not establish any Action Level (AL) values
for these hazardous substances. Of equal or greater significance, the table leaves out some of the
internationally known carcinogens, such as formaldehyde/formalin.

2. Formaldehyde
According to OSHA, formaldehyde describes various mixtures. The term “formalin” is
used to describe a saturated solution of formaldehyde. Formalin is typically 37% formaldehyde
by weight (40% by volume) and 6-13% methanol by volume in water. Formaldehyde is often
found in water-based solutions. The gas is colorless, strong-smelling,. Formaldehyde is also
widely used in particle boards, household products, glues, fiberboard, and plywood. It is also
used as an industrial fungicide, disinfectant and germicide.

2.1. Routes of Exposure
Formaldehyde can be inhaled as a gas or vapor or absorbed through the skin as a
liquid. Those with highest risk are healthcare professionals, medical lab technicians,
mortuary workers as well as teachers and students who handle biological specimens
preserved with formaldehyde or formalin (OSHA 2011).

2.2. Harmful Effects
As a sensitizing agent, formaldehyde can cause immune system response upon initial
exposure. Airborne exposure above 0.1 ppm can cause irritation of the respiratory tract.
Although the short-term health effects of formaldehyde exposure are well known, less is
known about its potential long-term health effects. In 1987, the U.S. Environmental
Protection Agency (EPA) classified formaldehyde as a probable human carcinogen under
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conditions of unusually high or prolonged exposure. In 2011, the National Toxicology
Program, an interagency program of the Department of Health and Human Services, named
formaldehyde as a known human carcinogen in its 12th Report on Carcinogens. A number of
studies involving workers exposed to formaldehyde have recently been completed. One
recent study, conducted by the U.S. National Cancer Institute (NCI), looked at workers in
industries with the potential for occupational formaldehyde exposure and estimated each
worker’s exposure to the chemical while at work. The results showed an increased risk of
death due to leukemia, particularly myeloid leukemia, among workers exposed to
formaldehyde (OSHA 2011).

2.3. Exposure Limits
The OSHA Formaldehyde standard, 29 CFR 1910.1048 provides the following
exposure limits:


The permissible exposure limit (PEL) for formaldehyde in the workplace is 0.75
ppm measured as an 8-hour time-weighted average (TWA).



PEL in the form of a short-term exposure limit (STEL) of 2 ppm (15-minute
period).



The action level (AL)– which is the standard’s trigger for increased industrial
hygiene monitoring and initiation of worker medical surveillance –is 0.5 ppm
when calculated as an 8-hour TWA.

In addition, the following recommended exposure limits are recognized:
 Ceiling limits: 0.3 ppm (ACGIH), 0.1 ppm- 15 minutes (NIOSH)
 NIOSH’s Recommended Exposure Level (REL) of 0.016 ppm (TWA)
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2.4. Formalin use in the Healthcare Industry
The safe use of formaldehyde is essential since the chemical has many uses in addition to
preserving bodies in the morgue. Formaldehyde is widely used in the healthcare industry; as
a fixative/ preservative of anatomical specimens. The overall goal of tissue fixation is to
preserve cells and tissue components in a “life-like state” and prepare them for the thinning
and staining sections. Fixation can be accomplished by chemical or physical means. The
most commonly used fixative agent is formalin. Formalin is used with the “quick fix”
method. Over the years alternative fixatives have been studied, such as Bouin and Hollande,
and newer products such as GreenFix, UPM and CyMol. A study published in The European
Journal of Histochemistry compared these fixatives. Each had their advantages and
disadvantages; none provided right combination of satisfactory qualities to replace formalin.
The point of that study, however, was to evaluate whether any of those reagents could
replace formalin in terms of test validation. The focus was not safe use or ease of disposal.
Despite its known health hazards, formalin is a key component of the histopathology and
pathology laboratory (Gatta 2012). As a critical step in the preparation of histological
sections, formalin plays a key role in preventing tissue deprivation after removal from the
body. Tissue specimens are removed from the patient. Afterwards, the tissue is transported
in a container containing formalin to the pathology laboratory. Due to issues of cost, revalidation and the need to evaluate long-term effects of alternate fixatives on tissue
preservation, it is unlikely that total elimination of formalin is likely or even possible.
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3. Hospital General de la Plaza de la Salud
Located in the nation’s capital, Santo Domingo, Hospital General de la Plaza de la Salud
(HGPS) is one of Dominican Republic’s largest teaching medical institutions. The hospital
opened its doors in 1996. As a teaching hospital, HGPS specializes in family and community
medicine, medical emergency and disasters, and
rehabilitation medicine.

Figure 2: Hospital de la Plaza de la Salud

Since its opening, the facility has not
undergone any major upgrades to its
infrastructure or its environment. In 2014, the
institution obtained the services of Baptist
Health International (BHI) for consultation and
hopes to improve the quality and safety of its
environment of care. Ultimately, the institution plans to achieve Joint Commission International
(JCI) accreditation by 2017. This accreditation process includes making major improvements in
quality and safety, to include proper handling of hazardous materials.

3.1.

Formaldehyde/Formalin use in HGPS
As part of BHI’s consultation, an industrial hygiene assessment was conducted in

September 2015. This assessment included reviewing the current usage, storage and
disposal of hazardous materials, to include formaldehyde/formalin. Currently, the
pathology department (to include the morgue area), the laboratory, and the sterilization
department all use formaldehyde. At the time of this assessment, the pathology
department was still using formaldehyde and diluting it into formalin. This practice is
highly discouraged in advanced countries, as it’s widely known to increase the potential
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of exposure via inhalation. The sterilization department was still using a formaldehyde
sterilizer.
Figure 3: Sterilizer (Sterilization Dept)

3.2.

Figure 4: Formalin container (Lab Dept)

Hazard Assessment (HGPS)
In order to properly identify and define each potential hazard, a robust literature

review took place, to include
any applicable OEL/REL.
This phase includes making
basic characterization thru
anticipation and recognition.
Using the ERAM Model,
this assessment was followed

Figure 5: Fundamental Elements of IH (ERAM Model)
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by an Exposure Risk Assessment.

3.3.

Exposure Risk Assessment (HGPS)
In order to determine exposure profiles, the effectiveness of current controls, and

address recent employee concerns, personal exposure and area monitoring took place.
To carefully select and effectively use resources, an overall plan for sampling, that
includes the type or number of samples, was necessary. Therefore, the NIOSH Sampling
Strategy was used to make the following determinations:


Chemical(s) are potentially released into the workplace based on processes



Written determination of employees above the AL for
formaldehyde/formalin



Need to measure exposure of maximum risk employees who may be
above the AL



Determine if exposure is above PEL/AL/STEL

Some of the objectives of this exposure assessment is to define similar exposure
groups (SEGs), their exposure profile, judge acceptability of the profile for each SEG,
and ultimately determine if current controls, to include engineering and personal
protective equipment, are adequately protecting workers.

3.4.

Establishing SEGs (HGPS)
In order to properly establish similar exposure groups (SEGs), the following

variables were considered during sampling:


Location,



Type of process/procedure,



Materials,
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3.5.



Environmental variables



Specific agent(s)



Engineering & administrative controls

Environmental Sampling (HGPS)
Using NIOSH’s sample determination chart and sampling method, the
following determinations were made:


Figure 6: Fume hood (Pathology)
Selected a full-period, continuous
sampling (using passive badges)



Evaluate potential
fluctuations/STEL monitoring by
using an instantaneous
photoionization detector (PID)
device (ppbRae 3000)



Employees were randomly selected
in the Pathology Department,
Clinical Laboratory Department,
and Surgical Services (includes Sterilization area)



In addition to monitoring for formalin/formaldehyde, the following
substances were also included in this IH assessment:
o Xylene (Pathology Dept)
o Alcohols (Pathology Dept and Laboratory Dept)
o Waste anesthetic gases (Surgical services)
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o Kem Medical was used as third party laboratory for analysis of passive
monitoring badges.
Figure 7: Passive monitors (Surgical Services staff)

4.0.

Results (HGPS)

Table 2- IH Monitoring Results (Pathology)-Results are all TWA
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ND*(Not detectable) NT* (Not tested)

Table 3- IH Monitoring Results (Clinical Laboratory)-Results all in TWA

Table 4- IH Monitoring Results (Surgical Services)
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5.0. Recommendations (HGPS)
Table 5- U.S. Federal Standards

The following findings and recommendations are based on U.S. Federal exposure
standards (Table 5):


Discontinue the practice of diluting formaldehyde to formalin.



Discontinue the use of faulty sterilizer (formaldehyde), as leaks have taken
place. Otherwise, provide adequate personal protection to staff, to include
respiratory protection to be used while the sterilizer using formaldehyde is in
use. Currently, staff are provided with half-face air purifying respirators.



Provide adequate hand and skin protection, to include gloves that adequately
protect from solvents.



Morgue Tech:
o

Potentially overexposed to formalin.

o Therefore, we recommend the following controls:


Discontinue the use of N-95 respirators and use NIOSH-approved
respirator for formaldehyde/formalin.



Do not perform formalin/biological tissue separation task. Dispose
of waste as hazardous waste or via separate waste streams under
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local exhaust ventilation or provide adequate personal protection,
including respiratory protection, to staff performing this task.


Install local exhaust ventilation or this morgue area should be
completely negative to adjacent areas.



Repeat IH monitoring once above is completed or when process
changes.



Histology Tech:
o Potential above normal exposure to isopropanol and potential fire hazard.
o Therefore, we recommend the following controls:


Histology tech’s task required local exhaust ventilation. This
ventilation is to be directly vented outside the building. Current
fume hood does NOT vent directly outside. In addition, this hood
does not have the necessary filtration for VOCs or flammables.
Furthermore, it was indicated that current filters are not replaced.
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Repeat IH monitoring once above is completed or when process
changes.

Figure 8: Morgue Tech-Pathology

6.0.

Conclusion
In conclusion, the Dominican Republic’s landmark Reglamento de Segurida y
Salud en el Trabajo, Decreto 522-06 (Health and Safety in the Workplace Act of 2006),
has set out to make major improvements within the workplace. This Act regulates some
hazards within the workplace and requires employers to establish risk prevention
initiatives, to include program management, in order to prevent illnesses and accidents
within the workplace.
Even though this Act makes noticeable advancements, it lacks specific guidelines
to protect workers from potential exposure to known carcinogens, such as formaldehyde.
As one of the biggest formalin/formaldehyde-using industries healthcare organizations
have little to no guidelines on how to properly use, store and ultimately dispose of this
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known human carcinogen. The exposure assessment and monitoring performed in one of
the country’s largest hospital, Hospital General de la Plaza de la Salud, shows the urgent
need to include this known human carcinogen in the Act’s Tabla Indicativa y No
Exhaustiva de Valores Limite (ACGIH TLV-TWA). In addition, similar to OSHA’s
Formaldehyde standard (29 CFR 1910.1048), the Act needs to provide specific guidance
on how to properly protect workers.
The above was evident by the existing current practices that place employees of
Hospital General de la Salud at risk of being overexposed to formalin and other VOCs. In
addition, the lack of regulation and guidelines provides a challenge for employees to
adequately recognize potential hazards and for employers to know how to properly
provide the necessary protection.
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Appendix A:

Strategy Assessing and Managing Occupational Exposures (3rd edition AIHA)
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Pathology Department (HGPS)
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Clinical Laboratory Area (HGPS)
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Appendix B:
OTM-Comparing to PELS

Laboratory Analysis information:
Methods of analysis:


Modified OSHA #103 (WAGs)



Modified OSHA #1400 (Alcohols)



NIOSH # 2016, OSHA#1007 (Formaldehyde/formalin)



Modified NIOSH# 1501 (Xylene)

Overall System Accuracy (OSA):


Isopropanol: +/- 12.28%



Ethanol: +/- 11.47%



Methanol: +/- 10.07
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Xylene: +/- 5.65 %



WAGs:
o +/- 7.23% (Sevoflurane)
o +/- 6.81% (Desflurane)
o +/- 10.89% (Isoflurane)



Formaldehyde: +/- 9.40%

Lowest Detectible Limit: 0.02 ppm (for all Vapors)

